# Neuroendocrine Mechanisms in Adiposity: An Integrated Approach to the Characterization of Potential Pharmacological Novel Targets Based on Experimental and Clinical Models

> **NCT06326853** · — · NOT_YET_RECRUITING · sponsor: **IRCCS San Raffaele** · enrollment: 200 (estimated)

## Conditions studied

- Endocrine Disorders
- Adiposity
- Pituitary Adenoma
- Cushing Syndrome
- Acromegaly
- Hypopituitarism

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT06326853
- **Lead sponsor:** IRCCS San Raffaele
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2024-07
- **Primary completion:** 2024-07
- **Final completion:** 2026-12
- **Target enrollment:** 200 (ESTIMATED)
- **Last updated:** 2024-06-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06326853

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06326853, "Neuroendocrine Mechanisms in Adiposity: An Integrated Approach to the Characterization of Potential Pharmacological Novel Targets Based on Experimental and Clinical Models". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06326853. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*